Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

218
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
218
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

221
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
221

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eravacycline in sepsis complicated by <i>Clostridioides difficile</i> infection: a brief case series.

Journal of chemotherapy (Florence, Italy)·2026
Same author

Comparing large language models for antibiotic prescribing: an updated analysis using the same clinical benchmark.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Implementing the National Vaccination Plan in people with HIV in Italy: A survey among ICONA centres.

HIV medicine·2026
Same author

Successful treatment of nodular scabies with long-lasting ivermectin dose schedule in an adult patient non responder to permethrin.

IDCases·2026
Same author

Cefepime and New Cefepime/Beta-Lactamase Inhibitor Combination for the Treatment of Gram-Negative Bacteria: Chemical Structure and Mechanism of Action, Microbiological Target, Clinical Use and PK/PD Characteristics.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Exploring the impact of Cabotegravir-Rilpivirine long-acting on weight gain, body composition and quality of life in adults living with HIV.

HIV medicine·2026

Related Experiment Video

Updated: Jun 25, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.6K

What do We Know about Cryptic Aspergillosis?

Nicholas Geremia1,2, Federico Giovagnorio3, Agnese Colpani4

  • 1Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Dell'Angelo, 30174 Venice, Italy.

Microorganisms
|May 25, 2024
PubMed
Summary
This summary is machine-generated.

Cryptic Aspergillus species are emerging fungal pathogens. Understanding their identification and management is crucial for human and animal health, emphasizing a One Health approach.

Keywords:
Aspergillusantifungal resistancesantifungal treatmentscryptic aspergillosisone health

More Related Videos

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
15:01

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

Published on: September 18, 2021

3.4K
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.0K

Related Experiment Videos

Last Updated: Jun 25, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.6K
Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung
15:01

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

Published on: September 18, 2021

3.4K
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.0K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Public Health

Background:

  • Cryptic Aspergillus species are increasingly identified as significant human pathogens.
  • These ubiquitous fungi exhibit environmental tenacity and possess resistance mechanisms, often linked to agricultural antifungal use.
  • Current knowledge on the number of cryptic species and their clinical impact remains limited.

Purpose of the Study:

  • To provide a comprehensive overview of cryptic Aspergillus species, focusing on accurate identification.
  • To discuss the improved management strategies for infections caused by these pathogens.
  • To highlight the necessity of a One Health approach for understanding and controlling these microorganisms.

Main Methods:

  • Comprehensive literature review.
  • Analysis of current molecular identification techniques.
  • Synthesis of information on antifungal resistance and clinical significance.

Main Results:

  • Molecular techniques are improving the identification of cryptic Aspergillus species.
  • These fungi pose a cross-sectional threat across animal, plant, and human health sectors.
  • A multidisciplinary approach is essential for effective management.

Conclusions:

  • Accurate identification and a One Health strategy are vital for managing cryptic Aspergillus infections.
  • Further research is needed to fully understand the scope and implications of these pathogens.
  • Addressing the economic and health burdens associated with these fungi requires enhanced knowledge and collaboration.